Real-time enrollment status for this i cannot determine the primary medical condition from the provided information. the study title only mentions "st-067" (which appears to be an investigational drug), and the conditions listed contain only drug/treatment names (st-067, obinutuzumab, and pembrolizumab) rather than medical conditions. the brief summary field appears to be incomplete. without information about the actual disease or condition being treated, i cannot extract a patient-facing medical condition. clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT04787042 |
| Recruiting Status | Recruiting |
| Condition | I cannot determine the primary medical condition from the provided information. The study title only mentions "ST-067" (which appears to be an investigational drug), and the conditions listed contain only drug/treatment names (ST-067, Obinutuzumab, and pembrolizumab) rather than medical conditions. The brief summary field appears to be incomplete. Without information about the actual disease or condition being treated, I cannot extract a patient-facing medical condition. |
| Phase | Clinical Trial |
| Target Enrollment | 316 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Simcha IL-18, Inc. |
| Last Updated on CT.gov | November 15, 2024 (Nov 15, 2024) |
As of March 2, 2026: Clinical trial NCT04787042 is currently recruiting participants. This clinical trial study for i cannot determine the primary medical condition from the provided information. the study title only mentions "st-067" (which appears to be an investigational drug), and the conditions listed contain only drug/treatment names (st-067, obinutuzumab, and pembrolizumab) rather than medical conditions. the brief summary field appears to be incomplete. without information about the actual disease or condition being treated, i cannot extract a patient-facing medical condition. is actively seeking new participants at 6 locations across the United States. The study is sponsored by Simcha IL-18, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04787042 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04787042 was last updated Nov 15, 2024 (November 15, 2024). HelloStudys verifies this status automatically.